Trials / Completed
CompletedNCT01029535
Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, open-label experience study to be conducted at 6 clinical sites in Australia, with the objective to collect efficacy and safety information for Juvederm® VOLUMA™ when used for volumising the mid-face and cheek area.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cross-linked hyaluronic acid gel | Cross-linked hyaluronic acid gel (Juvederm® VOLUMA™) up to 4 mLs injected in each side of the face. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-04-01
- Completion
- 2011-10-01
- First posted
- 2009-12-10
- Last updated
- 2016-03-09
- Results posted
- 2013-02-20
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01029535. Inclusion in this directory is not an endorsement.